edison tv
Healthcare
edison tv
Metals & Mining
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Synact Pharma has appointed Malin Wikstrand as interim CFO, following the planned departure of Björn Westberg (announced in September 2025). Ms Wikstrand has been with Synact since 2016 and most recently served as financial controller, bringing long-standing company knowledge and broad financial experience from listed companies. Management expects to appoint a permanent CFO in the coming months, coinciding with a key corporate inflection point marked by its forthcoming top-line data from the Phase IIb ADVANCE trial evaluating lead asset resomelagon in newly diagnosed rheumatoid arthritis.
Investment Companies | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.